This study aims to determine the prevalence of hyperacusis and misophonia among teachers and to explore how these auditory sensitivities may relate to occupational stress. By examining teachers' sensory challenges in school environments, the study seeks to contribute to a better understanding of their impact on professional well-being and to inform strategies that can improve working conditions.
Eligibility
Sex
ALL
Min age
22 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Teachers actively working in preschool, elementary, middle, or high schools.
* Age between 22 and 45 years.
* Willingness to participate and provide informed consent.
* No diagnosed hearing loss.
* No chronic illnesses.
* No diagnosed psychological or psychiatric disorders.
Exclusion Criteria:
* Individuals with hearing loss.
* Individuals with chronic illnesses.
* Individuals with serious psychological or psychiatric diagnoses.
* Individuals who are not actively teaching.
* Participants unwilling to provide informed consent.
Primary outcome measure(s)
Prevalence of Misophonia Among Teachers — Baseline (single assessment) The proportion of teachers identified as having misophonia based on predefined classification criteria using the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating greater misophonia severity. Misophonia severity is classified as none, mild, moderate, or severe according to established cutoff values.
Prevalence of Hyperacusis Among Teachers — Baseline (single assessment) The proportion of teachers identified as having hyperacusis based on predefined classification criteria using the Khalfa Hyperacusis Scale. The scale consists of 14 items scored on a 4-point Likert scale, with a total possible score of 0-42. Participants are classified as having "no hyperacusis" (≤15), "suspected hyperacusis" (16-28), or "hyperacusis" (≥29).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.